Holzbeierlein JM - Search Results

1

Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.

Kirk PS, Lotan Y, Zargar H, Fairey AS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobson NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Aning J, Shariat SF, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Grivas P, Garcia JA, Stephenson AJ, Shah JB, Daneshmand S, Spiess PE, van Rhijn BWG, Mertens L, Black P, Wright JL. Kirk PS, et al. Among authors: holzbeierlein jm. J Urol. 2023 May;209(5):882-889. doi: 10.1097/JU.0000000000003193. Epub 2023 Feb 16. J Urol. 2023. PMID: 36795962

2

Effects of spinal cord transection and MK-801 on CGRP immunostaining in the rat urinary bladder.

McNeill DL, Shew RL, Holzbeierlein JM, Papka RE. McNeill DL, et al. Among authors: holzbeierlein jm. Exp Neurol. 1992 Jun;116(3):339-44. doi: 10.1016/0014-4886(92)90012-f. Exp Neurol. 1992. PMID: 1587334

3

Macrophage inhibitory cytokine-1: possible bridge molecule of inflammation and prostate cancer.

Karan D, Holzbeierlein J, Thrasher JB. Karan D, et al. Cancer Res. 2009 Jan 1;69(1):2-5. doi: 10.1158/0008-5472.CAN-08-1230. Cancer Res. 2009. PMID: 19117979 Review.

4

Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors.

Byrd KM, Subramanian C, Sanchez J, Motiwala HF, Liu W, Cohen MS, Holzbeierlein J, Blagg BS. Byrd KM, et al. Chemistry. 2016 May 10;22(20):6921-31. doi: 10.1002/chem.201504955. Epub 2016 Apr 1. Chemistry. 2016. PMID: 27037933 Free PMC article.

5

Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer.

Holzbeierlein JM. Holzbeierlein JM. Cancer. 2011 Jul 1;117(13):2830-2. doi: 10.1002/cncr.25899. Epub 2011 Jan 24. Cancer. 2011. PMID: 21264843 Free article. No abstract available.

6

Complications of androgen-deprivation therapy for prostate cancer.

Holzbeierlein JM, Castle EP, Thrasher JB. Holzbeierlein JM, et al. Clin Prostate Cancer. 2003 Dec;2(3):147-52. doi: 10.3816/cgc.2003.n.022. Clin Prostate Cancer. 2003. PMID: 15040857 Review.

7

CGRP-immunoreactive primary afferent nerve fibers in the rat urinary bladder: effects of dorsal rhizotomy and MK-801.

McNeill DL, Harris CH, Holzbeierlein JM, Shew RL, Traugh NE Jr, Papka RE. McNeill DL, et al. Among authors: holzbeierlein jm. Exp Neurol. 1992 Dec;118(3):317-23. doi: 10.1016/0014-4886(92)90189-w. Exp Neurol. 1992. PMID: 1306489

8

Dose effect of soy supplementation in prostate cancer: a pilot study.

van Veldhuizen PJ, Thrasher JB, Ray G, Cherian R, Ward J, Holzbeierlein J, Gutow S, Banerjee SK. van Veldhuizen PJ, et al. Oncol Rep. 2006 Dec;16(6):1221-4. Oncol Rep. 2006. PMID: 17089041

9

Review of the bylaws changes from the Society of Urologic Oncology 2009.

Holzbeierlein JM. Holzbeierlein JM. Urol Oncol. 2009 Sep-Oct;27(5):465. doi: 10.1016/j.urolonc.2009.05.012. Urol Oncol. 2009. PMID: 19720300 No abstract available.

10

What effect does androgen suppression therapy have on frequency and timing of fatal myocardial infarctions?

Holzbeierlein JM. Holzbeierlein JM. Nat Clin Pract Oncol. 2008 Feb;5(2):74-5. doi: 10.1038/ncponc1003. Epub 2007 Oct 30. Nat Clin Pract Oncol. 2008. PMID: 17971802 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page